Musculoskeletal ambulation disability symptom complex as a risk factor of incident bone fragility fracture

다국어 초록 (Multilingual Abstract)

Objectives: Influence of presenting musculoskeletal ambulation disability symptom complex (MADS) on occurrence of bone fragility fracture (BFF) is investigated with retrospective cohort study.
Methods: A total of 931 subjects joined in the study. Subjects were selected as bone fragility risk positive in the fracture assessment tool questionnaire. Their assumed risk factors were harvested from the medical records and X-ray pictures. They were followed up at least 8 years consecutively, and occurrence of incident BFF was set as primary endpoint. Each assumed risk factor including MADS was evaluated using Cox regression analysis. Subjects were divided into 2 groups according to presence of MADS (GMADS and G-noMADS). Adjusted hazard ratios between the 2 groups was evaluated using Cox regression analysis. The statistical procedures were performed before and after propensity score matching (PSM) procedures in order to make parallel with assumed risk factors.
Results: Statistically significant risk factors within 5% were prevalent vertebral body fracture, disuse, MADS, cognitive disorder, hypertension, contracture, Parkinsonism, being female sex, hyperlipidemia, insomnia, T-score in the femoral neck ≤ -2.3, chronic kidney disease ≥ stage 2, chronic obstructive pulmonary diseases, glucocorticoid steroid administrated, and osteoarthritis in order of the adjusted hazard ratios (from highest to lowest). Adjusted hazard ratios between G-MADS and G-noMADS were 2.70 and 1.83 for before and after PSM, respectively.
Conclusions: MADS demonstrated as a significant risk factor of BFF occurrence. In treating osteoporosis, fall risk should be aware of as well as bone fragility risk.

참고문헌 (Reference)

1 Sattin RW, "The incidence of fall injury events among the elderly in a defined population" 131 : 1028-1037, 1990

2 Curtis EM, "The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide" 26 : 7-17, 2017

3 Kanis JA, "The diagnosis of osteoporosis" 9 : 1137-1141, 1994

4 Suzuki T, "Risk factors of musculoskeletal ambulation disability symptom complex(MADS). Frequent falls and sarcopenia according to aging" 18 : 1581-1587, 2008

5 Porthouse J, "Risk factors for fracture in a UK population : a prospective cohort study" 97 : 569-574, 2004

6 Krishnan V, "Regulation of bone mass by Wnt signaling" 116 : 1202-1209, 2006

7 Bardet JF, "Quadriceps contracture and fracture disease" 17 : 957-973, 1987

8 Armas LA, "Pathophysiology of osteoporosis : new mechanistic insights" 41 : 475-486, 2012

9 Geusens PP, "Osteoporosis and osteoarthritis : shared mechanisms and epidemiology" 28 : 97-103, 2016

10 Hayashi T, "Osteoarthritis of the knee joint as a cause of musculoskeletal ambulation disability symptom complex(MADS)" 18 : 1574-1580, 2008

11 de Paula FJA, "Novel insights into the relationship between diabetes and osteoporosis" 26 : 622-630, 2010

12 Hoshino Y, "Musculoskeletal ambulation disability symptom complex(MADS)" 48 : 630-632, 2011

13 Saarinen A, "Low density lipoprotein receptor-related protein 5(LRP5)mutations and osteoporosis, impaired glucose metabolism and hypercholesterolaemia" 72 : 481-488, 2010

14 Hagino H, "Locomotive syndrome and osteoporosis e importance of bone stroke prevention" 31 (31): 2021

15 Sugimoto T, "Lifestylerelated metabolic disorders, osteoporosis, and fracture risk in Asia : a systematic review" 9 : 49-56, 2016

16 Avidan AY, "Insomnia and hypotonic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes" 53 : 955-962, 2005

17 Kim SM, "Hip fracture in patients with non-dialysis-requiring chronic kidney disease" 31 : 1803-1809, 2016

18 Orimo H, "Guideline for prevention and treatment of osteoporosis" Committee of guideline for the prevention and treatment of osteoporosis in Japan

19 Compston J, "Glucocorticoid-induced osteoporosis : an update" 61 : 7-16, 2018

20 Iihara N, "Fragility fractures in older people in Japan based on the national health insurance claims database" 42 : 778-785, 2019

21 Zhao R, "Exercise interventions and prevention of fall-related fractures in older people : a meta-analysis of randomized controlled trials" 46 : 149-161, 2017

22 Weitzmann MN, "Estrogen deficiency and bone loss : an inflammatory tale" 116 : 1186-1194, 2006

23 Tsukutani Y, "Epidemiology of fragility fractures in Sakaiminato, Japan : incidence, secular trends, and prognosis" 26 : 2249-2255, 2015

24 Saito M, "Effects of collagen crosslinking on bone material properties in health and disease" 97 : 242-261, 2015

25 Ito H, "Diagnosis of musculoskeletal ambulation disability symptom complex(MADS)" 18 : 1560-1565, 2008

26 Kurra S, "Diabetes and bone health : the relationship between diabetes and osteoporosis-associated fractures" 27 : 430-435, 2011

27 Zhao F, "Correlation of oxidative stress-related biomarkers with postmenopausal osteoporosis : a systematic review and metaanalysis" 16 : 4-, 2021

28 Genant HK, "Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis the Study of Osteoporotic Fractures Research Group" 11 : 984-996, 1996

29 Inoue D, "COPD and osteoporosis : links, risks, and treatment challenges" 29 (29): 637-648, 2016

30 Manolagas SC, "Bone marrow, cytokines, and bone remodeling d emerging insights into the pathophysiology of osteoporosis" 332 : 305-311, 1995

31 Szulc P, "Abdominal aortic calcification : a reappraisal of epidemiological and pathophysiological data" 84 : 25-37, 2016